Effectiveness of Sotrovimab in the Omicron Storm Time: A Case Series

Effectiveness of Sotrovimab in the Omicron Storm Time: A Case Series

Neutralizing monoclonal antibodies (mAbs) for pre- and post-exposure prophylaxis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) are largely used to prevent the progression of the disease by blocking viral attachment, host cell entry, and infectivity. Sotrovimab, like other available...

Full description

Bibliographic Details
Main Authors: Gaetano Cicchitto, Lorena Cardillo, Davide Sequino, Paola Sabatini, Luisa Adamo, Rosita Marchitiello, Maurizio Viscardi, Loredana Cozzolino, Antonietta Cavallera, Marialuisa Bocchino, Alessandro Sanduzzi Zamparelli, Francesco Ferrigno, Esterina de Carlo, Claudio de Martinis, Giovanna Fusco
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Viruses
Subjects:
SARS-CoV-2
monoclonal antibody treatment
sotrovimab
variant of concern
Omicron variant
immune suppression
Online Access:https://www.mdpi.com/1999-4915/15/1/102

Similar Items

Similar Items